Serge Jacquot

Efficacy of Rituximab in Refractory Inflammatory Myopathies Associated with Anti- Synthetase Auto-Antibodies: An Open-Label, Phase II Trial

P. Grenier, M. Guiguet, E. Hachulla, 2015, PloS one.